Dermatology
| Psoriasis
Dermatology
Psoriasis

Apremilast improved patient-reported outcomes in patients with moderate to severe plaque psoriasis of the scalp: results of the phase 3, randomized STYLE study

book_2 Source: EADV Virtual - Poster session
calendar_today Published on Medfyle: November 2020

This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.

Key messages

  • Scalp psoriasis negatively impacts mental health, social functioning and quality of life.
  • In the STYLE study, significantly greater proportions of patients achieved improvement of 4 points or more in scalp and whole-body itch compared to placebo.
  • Over 16 weeks, quality of life was improved across many measures, including symptoms and feelings, and impact on daily activities, leisure, work and personal relationships.
Presenting Author
Read more arrow_downward Hide arrow_upward

Linda Stein Gold, MD
Henry Ford Health System; West Bloomfield, MI, USA


Feedback